{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:51:07Z","timestamp":1791363067679,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019484","name":"Merit Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejca.2025.115607","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:02:46Z","timestamp":1751713366000},"page":"115607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients \u2013 Results from the prospective AXSANA registry trial"],"prefix":"10.1016","volume":"226","author":[{"given":"Rosa","family":"Di Micco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Banys-Paluchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"de Boniface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ditsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guldeniz","family":"Karadeniz Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Thill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Patrick","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christian","family":"Kolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel T.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Gasparri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard-Alexandru","family":"Bonci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Niinikoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Murawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Peintinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Schlichting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helidon","family":"Nina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagigat","family":"Valiyeva Qanimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Vanhoeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Rebaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Kadayaprath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste Davide","family":"Gentilini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115607_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib2","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib3","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2025.115607_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.20406","article-title":"Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection","volume":"93","author":"Schulze","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib5","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1245\/s10434-023-13191-2","article-title":"Ten-year oncologic outcomes in T1-3N1 breast cancer after targeted axillary sampling: a retrospective study","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study","volume":"13","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2025.115607_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bjs\/znac217","article-title":"Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey","volume":"10","author":"Gasparri","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2025.115607_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00404-019-05428-x","article-title":"Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature","volume":"301","author":"Banys\u2011Paluchowski","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejca.2025.115607_bib9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jmri.28399","article-title":"Different imaging modalities for the diagnosis of axillary lymph node metastases in breast cancer: a systematic review and network meta-analysis of diagnostic test accuracy","volume":"57","author":"Li","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejca.2025.115607_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","article-title":"Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla","volume":"254","author":"Houssami","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2025.115607_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2214\/AJR.05.0936","article-title":"Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review","volume":"186","author":"Alvarez","year":"2006","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejca.2025.115607_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF02303476","article-title":"Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer","volume":"5","author":"Kuerer","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.breast.2016.11.012","article-title":"Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial","volume":"31","author":"Schwentner","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2025.115607_bib15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejso.2019.01.219","article-title":"Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: time trend, imaging staging power and nodal downstaging according to molecular subtype","volume":"45","author":"Di Micco","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/jjco\/hyab117","article-title":"Breast cancer subtypes affect the ultrasound performance for axillary lymph node status evaluation after neoadjuvant chemotherapy: a retrospective analysis","volume":"51","author":"Fei","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","article-title":"Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 trial (Alliance)","volume":"210","author":"Le-Petross","year":"2018","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejca.2025.115607_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5858\/133.4.633","article-title":"Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting","volume":"133","author":"Sahoo","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2025.115607_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the reporting of observational studies in epidemiology(STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejca.2025.115607_bib20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib21","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115607_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2\u2013positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib23","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","article-title":"Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)","volume":"24","author":"Schneeweiss","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(18)30570-9","article-title":"Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"van Ramshorst","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2025.115607_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","volume":"273","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2025.115607_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2014.09.020","article-title":"Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review","volume":"84","author":"Schipper","year":"2015","journal-title":"Eur J Radio"},{"key":"10.1016\/j.ejca.2025.115607_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","article-title":"The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)","volume":"35","author":"Peppe","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2025.115607_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89738-8","article-title":"Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node\u2011positive breast cancer according to breast cancer subtype","volume":"11","author":"Maeshima","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2025.115607_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","article-title":"Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases","volume":"163","author":"van Nijnatten","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2025.115607_bib32","article-title":"Nodal burden and oncologic outcomes in patients with residual isolated tumor cells after neoadjuvant chemotherapy (ypN0i+): the OPBC-05\/ICARO study","author":"Montagna","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib33","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","article-title":"Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer","volume":"26","author":"Wong","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","article-title":"Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18","volume":"95","author":"Fisher","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2025.115607_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54017-0","article-title":"Diagnostic performance of axillary ultrasound and standard breast MR for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients","volume":"9","author":"Samiei","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2025.115607_bib36","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/cancers13143571","article-title":"PET\/MRI for staging the axilla in breast cancer: current evidence and the rationale for SNB vs. PET\/MRI trials","volume":"13","author":"Di Micco","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2025.115607_bib37","article-title":"Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: a multicentre, retrospective cohort study","volume":"30","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejca.2025.115607_bib38","article-title":"Prediction of axillary lymph node metastasis in early breast cancer patients with ultrasonic videos based deep learning","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115607_bib39","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.3390\/cancers12123698","article-title":"O. Avoiding axillary sentinel lymph node biopsy after neoadjuvant systemic therapy in breast cancer: rationale for the prospective, multicentric EUBREAST-01 trial","volume":"12","author":"Reimer","year":"2020","journal-title":"Cancers"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925003892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925003892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:06:28Z","timestamp":1791360388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925003892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"alternative-id":["S0959804925003892"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115607","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients \u2013 Results from the prospective AXSANA registry trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115607"}}